December 10, 2015—The Senate Special Committee on Aging kicked off a series of hearings about drug price inflation yesterday with a session on skyrocketing prices for off-patent drugs lacking competition. … [Read more...]
Four 340B Hospitals Cared for San Bernardino Shooting Victims
Received 15 of the 21 who were woundedDecember 4, 2015—Four California hospitals enrolled in the 340B program cared for victims of the Dec. 2 mass shooting in San Bernardino, Calif. … [Read more...]
HRSA Aims to Issue Final 340B Mega-guidance by Late Summer
December 1, 2015—Federal health officials are aiming for September 2016 as the target for publishing final omnibus guidance for the 340B program. … [Read more...]
HRSA Publishes Process for Self-Reporting 340B Noncompliance
Repeats protocol issued last yearDecember 1, 2015—The Health Resources and Services Administration is repeating its recommendation that healthcare providers follow a specific protocol for disclosing to the government and drug manufacturers that they have violated 340B program requirements. … [Read more...]
OIG Releases 340B Shared Savings Report
Three ways Medicare and beneficiaries could tap providers' discountsNovember 24, 2015—The Department of Health and Human Services Office of Inspector General today outlined three ways that Medicare and its beneficiaries might share safety-net healthcare providers' 340B drug discount savings. … [Read more...]
Hospitals Share Concerns About HRSA’s 340B Guidance with Congress
Changes will harm their ability to care for vulnerable patientsNovember 20, 2015—Proposed 340B drug discount policy changes – especially those affecting discharge prescriptions, physician eligibility, and infusion drugs – will jeopardize hospitals' ability to care for vulnerable patients if the government finalizes them as is, hospital leaders warned at a Capitol Hill briefing yesterday. … [Read more...]
HHS Holds Forum on Rising Drug Prices
Manufacturers say insurers and providers deserve a closer look for their roleNovember 20, 2015—U.S. Health and Human Services Secretary Sylvia Mathews Burwell today opened a forum on the high and growing cost of prescription drugs with a challenge to government agencies, pharmaceutical manufacturers, patient advocates, providers, employers, and payers to come together "to find a path that doesn’t ask us to choose between innovation and affordability." … [Read more...]